13F-HR filed by Boxer Capital, LLC
Boxer Capital, LLC filed this 13F-HR for the quarter ended 2015-12-31, filed 2016-02-16, with 15 holding rows worth $115,825,000.
- Accession
- 0000950123-16-015087
- Filer
- CIK 1465837
- Filed
- 2016-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2015
A holdings report, 15 entries on the cover page, a total value of $115,825,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $115,826,000 with VALUE read as thousands by filing date, 13F file number 028-17339. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerAviva Holdings Ltd.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 2,023,232 | $63,934,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 809,415 | $10,101,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 313,626 | $8,261,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 160,000 | $7,181,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 654,595 | $5,499,000 | thousands by filing date | |
| VITAE PHARMACEUTICALS INC | 92847N103 | COM | 250,270 | $4,530,000 | thousands by filing date | |
| ARADIGM CORP | 038505400 | COM NO PAR NEW | 1,101,513 | $4,373,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 225,000 | $3,317,000 | thousands by filing date | |
| CELLADON CORP | 15117E107 | Cmn | 1,399,991 | $2,058,000 | thousands by filing date | |
| AKARI THERAPEUTICS PLC | 00972G108 | ADR | 139,899 | $2,029,000 | thousands by filing date | |
| SOPHIRIS BIO INC F | 83578Q209 | FOREIGN CANADIAN | 1,000,000 | $1,780,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS AG | 62957M104 | SPONSORED ADR | 176,710 | $1,688,000 | thousands by filing date | |
| NEXVET BIOPHARMA PLC | G6503X109 | ORD SHS | 154,840 | $528,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 63,146 | $428,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H104 | COM | 28,100 | $119,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-16-015087 | this filing | 2016-02-16 | acceptance time not in the bulk data set |